SRC-3 treatment decreased tumor growth in a Jeko-1 ibrutinib resistant mouse model. by Imani Bijou (18275174)

Inotodiol decreases clone formation in HCC cells. by Yushuang Xing (20636685)

“…<div><p>Hepatocellular carcinoma(HCC) has a high mortality and morbidity rate and seriously jeopardizes human life. …”

<i>CHGA</i> mRNA expression decreases with <i>CYB561</i> knockdown. by Romie Angelo G. Azur (18547651)

Decreased deaminase activity in A12-infected cells despite a high level of A3B protein. by Noémie Lejeune (9243785)

<i>CYB561</i> knockdown decreased the survival, proliferation, and migration rates of PC-3 cells. by Romie Angelo G. Azur (18547651)

Discovery of a Potent and Oral Available Complex I OXPHOS Inhibitor That Abrogates Tumor Growth and Circumvents MEKi Resistance by Peng He (24579)

Subjects:

Discovery of a Potent and Oral Available Complex I OXPHOS Inhibitor That Abrogates Tumor Growth and Circumvents MEKi Resistance by Peng He (24579)

Subjects:

Discovery of a Potent and Oral Available Complex I OXPHOS Inhibitor That Abrogates Tumor Growth and Circumvents MEKi Resistance by Peng He (24579)

Subjects:

Discovery of a Potent and Oral Available Complex I OXPHOS Inhibitor That Abrogates Tumor Growth and Circumvents MEKi Resistance by Peng He (24579)

Subjects:

Discovery of a Potent and Oral Available Complex I OXPHOS Inhibitor That Abrogates Tumor Growth and Circumvents MEKi Resistance by Peng He (24579)

Subjects:

Discovery of a Potent and Oral Available Complex I OXPHOS Inhibitor That Abrogates Tumor Growth and Circumvents MEKi Resistance by Peng He (24579)

Subjects:

High expression of Rpl22L1 is correlated with poor survival in CRC. by Shuyun Rao (449181)

Subjects:

NeuroD1 increases HCC cell death resistance. by Ping Huang (30439)

Subjects:

<i>RPL22</i> is frequently deleted in CRC and its loss results in induction of its highly homologous paralog, Rpl22L1. by Shuyun Rao (449181)

Subjects:

Low ATF3 expression is associated with decreased survival and EZH2 and ATF3 signatures inversely correlate in human prostate cancers. by Amy E. Schade (15368259)

Subjects:

mRNA expression levels of NeuroD1 and GPX4 in clinical tumor samples. by Ping Huang (30439)

Subjects:

Tumors from vehicle-treated mice were collected at the end of study, homogenized, and assessed for expression of FGFR1, vimentin, and β-actin. by Angela Abdollahi (15166230)

Subjects:

NeuroD1/GPX4 axis promotes HCC cell ferroptosis resistance and tumorigenic potential. by Ping Huang (30439)

Subjects:

NeuroD1 directly binds to the <i>GPX4</i> promoter and regulates its transcriptional activity in MHCC-97H cells. by Ping Huang (30439)

Subjects:

NeuroD1 inhibits HCC cell ferroptosis. by Ping Huang (30439)

Subjects: